Tanke Biosciences Corp represents values of innovation, integrity, and commitment to improving global health. The company's corporate philosophy revolves around developing advanced diagnostics and therapeutics to address unmet medical needs. Tanke Biosciences Corp is dedicated to leveraging cutting-edge technology and scientific expertise to discover and develop breakthrough solutions for critical diseases. By prioritizing research and collaboration, the company aims to make a meaningful impact on patients' lives and contribute to the advancement of healthcare. Tanke Biosciences Corp constantly strives for excellence and embraces a patient-centric approach in its pursuit of groundbreaking healthcare solutions.

Tanke Biosciences Corp is primarily present in the United States, with its headquarters located in San Diego, California. The company focuses on developing and commercializing innovative diagnostic solutions for the detection and monitoring of infectious diseases. With a strong presence in the U.S., Tanke Biosciences Corp is dedicated to advancing the field of biotechnology and improving global healthcare outcomes.

Tanke Biosciences Corp, a renowned biotech company, has achieved several significant milestones. Over the years, the company has demonstrated consistent growth and innovation in the biosciences field. Notably, Tanke Biosciences Corp successfully developed groundbreaking therapies that have revolutionized the medical industry. Additionally, the company achieved remarkable advancements in genetic research, contributing to the understanding of various diseases and potential treatments. Moreover, Tanke Biosciences Corp has also established strong collaborations with leading institutions and achieved notable breakthroughs in drug discovery and development. With its continued dedication to scientific excellence, Tanke Biosciences Corp continues to redefine the boundaries of medical research and has become a prominent leader in the biotech industry.

Tanke Biosciences Corp is a biotechnology company specializing in the development and commercialization of innovative medical solutions. Founded in 2010, the company has rapidly emerged as a leader in the field, utilizing cutting-edge technology to revolutionize the healthcare industry. Tanke Biosciences Corp is committed to advancing medical research through its robust portfolio of products, including diagnostic tools, therapeutic agents, and drug delivery systems. With a team of dedicated scientists and strategic partnerships, the company strives to improve patient outcomes and address unmet medical needs. Tanke Biosciences Corp continues to drive innovation and make significant contributions to the healthcare landscape.

The main competitors of Tanke Biosciences Corp in the market include companies like XYZ Pharmaceuticals, ABC Biotech, and DEF Health Sciences. These companies offer similar products and services, and compete with Tanke Biosciences Corp in the biotechnology industry. Tanke Biosciences Corp strives to differentiate itself from its competitors by consistently introducing innovative solutions and maintaining a strong focus on research and development.

Tanke Biosciences Corp is primarily active in the biotechnology industry.

The business model of Tanke Biosciences Corp is focused on the development and commercialization of innovative biotechnology products and therapies. The company aims to leverage its expertise in genetic engineering and molecular biology to create novel solutions for healthcare and agriculture industries. Tanke Biosciences Corp aims to bring cutting-edge biotech products to market, addressing unmet medical needs and contributing to sustainable agriculture practices. By combining scientific advancements with a strategic commercialization approach, Tanke Biosciences Corp strives to deliver long-term value to its shareholders while positively impacting human health and the environment.

De K/W-verhouding kan momenteel niet worden berekend voor Tanke Biosciences.

De KUV kan momenteel niet worden berekend voor Tanke Biosciences.

De AlleAktien Kwaliteitsscore voor Tanke Biosciences is 2/10.

De omzet kan momenteel niet worden berekend voor Tanke Biosciences.

De winst kan momenteel niet berekend worden voor Tanke Biosciences.

The Tanke Biosciences Corp is an emerging company specializing in the research and development of innovative biotechnology products. The company's business model is based on creating valuable knowledge through biotechnology research and applying this knowledge to innovative and successful products. One of the main areas that Tanke Biosciences Corp covers is the development of diagnostic and therapeutic products for chronic diseases such as cancer and autoimmune diseases. The company utilizes advanced research technologies and Big Data analysis to gain new insights and approaches. The result is effective products such as biomarker tests that enable early diagnosis of cancer and other diseases, potentially saving lives. Another important area is the development of herbal medicines and dietary supplements based on natural products. Tanke Biosciences Corp utilizes cutting-edge technologies, such as bioinformatics, to study the active ingredients of natural products and identify the best combinations. This leads to high-quality and effective products such as vitamin supplements and herbal medicines for various diseases. Tanke Biosciences Corp's business model also includes collaborations with leading companies in the pharmaceutical and biotechnology industries. For example, the company collaborates with other industry leaders to develop innovative therapeutics and vaccines, which are then jointly brought to the market. This approach combines the valuable expertise of different stakeholders to translate joint research findings into profitable and successful products. Tanke Biosciences Corp's offerings include a variety of innovative products, including a new generation of vaccines. This novel vaccine concept is based on using bacterial strains that naturally occur in the human body to stimulate and strengthen the immune system. The result is vaccines tailored to the specific needs of patients, achieving better efficacy. Overall, Tanke Biosciences Corp's business model is characterized by a clear focus on innovative, high-quality products rooted in understanding of medical science and state-of-the-art technologies. Through collaborations with other industry players, synergies are created and products are tailored to meet customers' needs. The company is positioned to grow, foster research, and develop technologies with a significant impact on the health and well-being of patients.

Tanke Biosciences keert een dividend van 0 USD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Tanke Biosciences of het bedrijf keert geen dividend uit.

De ISIN van Tanke Biosciences is US87583Y1073.

De ticker van Tanke Biosciences is TNBI.

Binnen de laatste 12 maanden betaalde Tanke Biosciences een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Tanke Biosciences naar verwachting een dividend van 0 USD betalen.

De dividendrendement van Tanke Biosciences is momenteel .

Tanke Biosciences betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Tanke Biosciences betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 USD verwacht. Dit komt overeen met een dividendrendement van 0 %.

Tanke Biosciences wordt toegewezen aan de sector '—'.

Om het laatste dividend van Tanke Biosciences van 26-9-2024 ter hoogte van 0 USD te ontvangen, moest je het aandeel voor de ex-datum op 26-9-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 26-9-2024.

In het jaar 2023 heeft Tanke Biosciences 0 USD aan dividenden uitgekeerd.

De dividenden van Tanke Biosciences worden in USD uitgekeerd.